- Home
- THRD vs RMM Comparison
THRD vs RMM Comparison
Compare THRD & RMM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- THRD
- RMM
- Stock Information
- Founded
- THRD 2019
- RMM 2019
- Country
- THRD United States
- RMM United States
- Employees
- THRD N/A
- RMM N/A
- Industry
- THRD Biotechnology: Pharmaceutical Preparations
- RMM Trusts Except Educational Religious and Charitable
- Sector
- THRD Health Care
- RMM Finance
- Exchange
- THRD Nasdaq
- RMM Nasdaq
- Market Cap
- THRD 238.7M
- RMM 271.2M
- IPO Year
- THRD 2022
- RMM N/A
- Fundamental
- Price
- THRD $5.46
- RMM $13.77
- Analyst Decision
- THRD Hold
- RMM
- Analyst Count
- THRD 3
- RMM 0
- Target Price
- THRD $5.00
- RMM N/A
- AVG Volume (30 Days)
- THRD 220.4K
- RMM 66.5K
- Earning Date
- THRD 08-07-2025
- RMM 01-01-0001
- Dividend Yield
- THRD N/A
- RMM 7.33%
- EPS Growth
- THRD N/A
- RMM N/A
- EPS
- THRD N/A
- RMM 0.96
- Revenue
- THRD N/A
- RMM N/A
- Revenue This Year
- THRD N/A
- RMM N/A
- Revenue Next Year
- THRD N/A
- RMM N/A
- P/E Ratio
- THRD N/A
- RMM $15.55
- Revenue Growth
- THRD N/A
- RMM N/A
- 52 Week Low
- THRD $3.18
- RMM $12.32
- 52 Week High
- THRD $16.02
- RMM $16.10
- Technical
- Relative Strength Index (RSI)
- THRD 66.73
- RMM 64.12
- Support Level
- THRD $5.42
- RMM $13.51
- Resistance Level
- THRD $5.45
- RMM $13.63
- Average True Range (ATR)
- THRD 0.04
- RMM 0.09
- MACD
- THRD -0.01
- RMM 0.04
- Stochastic Oscillator
- THRD 50.00
- RMM 96.06
About THRD Third Harmonic Bio Inc.
Third Harmonic Bio Inc is a biopharmaceutical company focused on the development of the next wave of medicine for the treatment of inflammatory diseases, including dermal, respiratory, and gastrointestinal diseases. The company's product candidate, THB001, is a selective, oral small-molecule inhibitor of KIT, a cell surface receptor that serves as the master regulator of mast cell function and survival. Its other product candidate THB335, is a potent, selective, oral small molecule KIT inhibitor, for the treatment of multiple mast cell-driven inflammatory diseases of the skin, airway, and gastrointestinal tract.
About RMM RiverNorth Managed Duration Municipal Income Fund Inc.
RiverNorth Managed Duration Muni Inc Fd is a United States based diversified, closed-end management investment company. Its primary investment objective is current income exempt from regular U.S. federal income taxes. The Fund's secondary investment objective is total return.